Vaishali Pharma Limited (VAISHALI) - Total Liabilities

Latest as of June 2026: Rs-691.15 Million INR ≈ $-7.47 Million USD

Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has total liabilities worth Rs-691.15 Million INR (≈ $-7.47 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VAISHALI cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Vaishali Pharma Limited - Total Liabilities Trend (2013–2026)

This chart illustrates how Vaishali Pharma Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Vaishali Pharma Limited (VAISHALI) total assets.

Vaishali Pharma Limited Competitors by Total Liabilities

The table below lists competitors of Vaishali Pharma Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Wizz Air Holdings PLC LSE:WIZZ	UK	GBX9.46 Billion
Gaming Corps AB ST:GCOR	Sweden	Skr42.96 Million
Gratifii Ltd AU:GTI	Australia	AU$16.47 Million
Cannabist Company Holdings Inc NEO:CBST	Canada	CA$689.46 Million
ICH Co Ltd KQ:368600	Korea	₩70.61 Billion
Active Biotech AB ST:ACTI	Sweden	Skr11.00 Million
Putprop Ltd JSE:PPR	South Africa	ZAC477.30 Million
Sri Adhikari Brothers Television Network Limited NSE:SABTNL	India	Rs171.45 Million

Liability Composition Analysis (2013–2026)

This chart breaks down Vaishali Pharma Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Vaishali Pharma Limited net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Vaishali Pharma Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Vaishali Pharma Limited (2013–2026)

The table below shows the annual total liabilities of Vaishali Pharma Limited from 2013 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs542.74 Million ≈ $5.87 Million	+20.80%
2025-03-31	Rs449.29 Million ≈ $4.86 Million	+21.05%
2024-03-31	Rs371.16 Million ≈ $4.01 Million	-3.28%
2023-03-31	Rs383.76 Million ≈ $4.15 Million	-30.57%
2022-03-31	Rs552.70 Million ≈ $5.98 Million	-13.24%
2021-03-31	Rs637.05 Million ≈ $6.89 Million	+42.13%
2020-03-31	Rs448.23 Million ≈ $4.85 Million	-5.34%
2019-03-31	Rs473.52 Million ≈ $5.12 Million	+8.30%
2018-03-31	Rs437.22 Million ≈ $4.73 Million	+7.21%
2017-03-31	Rs407.80 Million ≈ $4.41 Million	-12.34%
2016-03-31	Rs465.19 Million ≈ $5.03 Million	+9.30%
2015-03-31	Rs425.60 Million ≈ $4.60 Million	-15.48%
2014-03-31	Rs503.56 Million ≈ $5.45 Million	+9.93%
2013-03-31	Rs458.09 Million ≈ $4.95 Million	--

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$12.40 Million

Rs1.15 Billion INR

Market Cap Rank

#26589 Global

#1471 in India

Share Price

Rs8.79

Change (1 day)

+0.11%

52-Week Range

Rs4.88 - Rs12.11

All Time High

Rs42.57